SCHEMBL23102415

SCHEMBL23102415

Cc1c(Br)cccc1-c1nc2c(=O)n(CCO)ccc2s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 3/20 0.37
CD274 Q9NZQ7 3/20 0.37
KDM4E B2RXH2 4/20 0.35
MAPT P10636 4/20 0.35
S1PR2 O95136 3/20 0.35
ALDH1A1 P00352 3/20 0.35
GLA P06280 3/20 0.35
GAA P10253 3/20 0.35
HPGD P15428 3/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
ATM Q13315 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
HSD17B13 Q7Z5P4 1/20 0.35
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23102656 0.80 TRPC5 (0.33) PDCD1CD274TRPC5
SCHEMBL23102583 0.76 USP2 (0.35) PDCD1CD274KDM4EMAPTALDH1A1
SCHEMBL23102399 0.71 PARP1 (0.37) PDCD1CD274KDM4EMAPTALDH1A1
SCHEMBL23102431 0.69 KDM4E (0.35) PDCD1CD274KDM4EMAPTALDH1A1
SCHEMBL23102694 0.69 USP2 (0.33) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL23102477 0.68 PDCD1 (0.34) PDCD1CD274KDM4EMAPTALDH1A1
SCHEMBL23102693 0.67 USP2 (0.33) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL23102594 0.66 TP53 (0.33) PDCD1CD274KDM4EMAPTALDH1A1
SCHEMBL23624312 0.66 KDM4E (0.35) PDCD1CD274KDM4EMAPTALDH1A1
SCHEMBL21595152 0.64 HDAC3 (0.39) KDM4EALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021047556-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF 上海长森药业有限公司 2021-03-18 WO disclosed